Long-Term Combined Effects of Citrulline and Nitrate-Rich Beetroot Extract Supplementation on Recovery Status in Trained Male Triathletes: A Randomized, Double-Blind, Placebo-Controlled Trial.
シトルリンと硝酸塩豊富なビートルートエキスの長期併用摂取がトレーニング済み男性トライアスリートの回復状態に及ぼす影響:無作為化二重盲検プラセボ対照試験 (機械翻訳の邦題)
記録の確認項目
- 研究デザイン
- その他の原著論文
- 対象
- 未確定
- 出版年
- 2022
- 出典
- doi.org
- 抄録の表示
- 表示あり
- 出版状態
- 有効な記録
- 状態確認日
- 2026/08/17
- 収集日
- 2026/08/03
- 鮮度
- 確認期限内
- 確認段階
- 自動処理
- 記録状態
- 公開
日本語要約(機械生成)
本研究は、シトルリン(CIT)と硝酸塩豊富なビートルートエキス(BR)の長期併用摂取が、トレーニング済み男性トライアスリートの回復状態に及ぼす影響を検討した無作為化二重盲検プラセボ対照試験である。32名をプラセボ群、CIT群(3g/日)、BR群(2.1g/日、硝酸塩300mg/日)、CIT+BR群(3g/日CIT+2.1g/日BR)の4群に割り付け、9週間の摂取前後でクーパーテストの走行距離、筋損傷マーカー(尿素、クレアチニン、AST、ALT、GGT、LDH、CK)、ホルモン(テストステロン、コルチゾール、T/C比)を測定した。筋損傷マーカーに有意な群間差はなかったが、走行距離、コルチゾール、T/C比に有意な交互作用が認められた。CIT+BR群はプラセボ群とCIT群に比べ走行距離の変化率が有意に高く、プラセボ群に比べコルチゾールの増加抑制とT/C比の増加が認められた。結論として、CIT+BRの併用は筋損傷には効果がないが、コルチゾール上昇を抑え、走行距離とT/C比を改善することで回復状態を向上させる可能性が示唆された。
この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。
抄録
Citrulline (CIT) and nitrate-rich beetroot extract (BR) are widely studied ergogenic aids. Nevertheless, both supplements have been studied in short-term trials and separately. To the best of the authors' knowledge, the effects of combining CIT and BR supplementation on recovery status observed by distance covered in the Cooper test, exercise-induced muscle damage (EIMD) and anabolic/catabolic hormone status have not been investigated to date. Therefore, the main purpose of this research was to assess the effect of the long-term (9 weeks) mixture of 3 g/day of CIT plus 2.1 g/day of BR (300 mg/day of nitrates (NO3-)) supplementation on recovery by distance covered in the Cooper test, EIMD markers (urea, creatinine, AST, ALT, GGT, LDH and CK) and anabolic/catabolic hormones (testosterone, cortisol and testosterone/cortisol ratio (T/C)) in male trained triathletes. Thirty-two triathletes were randomized into four different groups of eight triathletes in this double-blind, placebo-controlled trial: placebo group (PLG), CIT group (CITG; 3 g/day of CIT), BR group (BRG; 2.1 g/day of BR (300 mg/day of NO3-)) and CIT-BR group (CIT-BRG; 3 g/day of CIT plus 2.1 g/day of BR (300 mg/day of NO3-)). Distance covered in the Cooper test and blood samples were collected from all participants at baseline (T1) and after 9 weeks of supplementation (T2). There were no significant differences in the interaction between group and time in EIMD markers (urea, creatinine, AST, ALT, GGT, LDH and CK) (p > 0.05). However, significant differences were observed in the group-by-time interaction in distance covered in the Cooper test (p = 0.002; η2p = 0.418), cortisol (p = 0.044; η2p = 0.247) and T/C (p = 0.005; η2p = 0.359). Concretely, significant differences were observed in distance covered in the Cooper test percentage of change (p = 0.002; η2p = 0.418) between CIT-BRG and PLG and CITG, in cortisol percentage change (p = 0.049; η2p = 0.257) and in T/C percentage change (p = 0.018; η2p = 0.297) between CIT-BRG and PLG. In conclusion, the combination of 3 g/day of CIT plus 2.1 g/day of BR (300 mg/day of NO3-) supplementation for 9 weeks did not present any benefit for EIMD. However, CIT + BR improved recovery status by preventing an increase in cortisol and showing an increase in distance covered in the Cooper test and T/C.
DOI 10.3390/biology11010075
PMID 35053073
原文・出典を見る →